Skip to main content
. 2023 May 1;80(6):634–641. doi: 10.1001/jamaneurol.2023.0932

Table 2. Risk of Parkinson Disease According to Rheumatoid Arthritis (RA) Status and Serologic Status of RA.

No. Event, No. Duration, person-y Incidence rate (per 1000 person-y) HR (95% CI)a
Crude Model 1 Model 2 Model 3
By RA status
Control 273 400 803 1237 781.0 0.65 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
RA 54 680 290 243 582.6 1.19 1.84 (1.61-2.10) 1.89 (1.65-2.16) 1.87 (1.63-2.14) 1.74 (1.52-1.99)
By RA status and seropositivity
Control 273 400 803 1 237 781.0 0.65 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
SNRA 15 670 56 68 804.0 0.81 1.26 (0.96-1.65) 1.34 (1.02-1.75) 1.31 (1.00-1.71) 1.20 (0.91-1.57)
SPRA 39 010 234 174 778.6 1.34 2.07 (1.79-2.39) 2.10 (1.81-2.43) 2.09 (1.80-2.41) 1.95 (1.68-2.26)
By seropositivity
SNRA 15 670 56 68 804.0 0.81 1 [Reference] 1 [Reference] 1 [Reference] 1 [Reference]
SPRA 39 010 234 174 778.6 1.34 1.65 (1.23-2.21) 1.56 (1.16-2.09) 1.59 (1.19-2.14) 1.61 (1.20-2.16)

Abbreviations: HR, hazard ratio; SNRA, seronegative rheumatoid arthritis; SPRA, seropositive rheumatoid arthritis.

a

Model 1 was adjusted for age, sex, smoking, alcohol drinking, physical activity, low income, and body mass index; model 2 was adjusted additionally for diabetes, hypertension, hyperlipidemia, and chronic kidney disease; and model 3 was adjusted additionally for myocardial infarction, stroke, and depression.